BioSurface Technologies

BioSurface Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $22.2M

Overview

BioSurface Technologies is a long-established, niche player in the research tools sector, providing essential laboratory equipment for biofilm investigation. The company's core business is the design and sale of physical reactor systems and flow cells that enable standardized, reproducible biofilm growth and analysis for academic, industrial, and public health laboratories. Its products are often developed in partnership with authoritative entities like the CDC and the Center for Biofilm Engineering, lending them credibility and establishing them as ASTM-approved methods. BST operates as a private, revenue-generating business model focused on serving the global research community with specialized hardware.

Medical DevicesDrug Delivery

Technology Platform

Hardware platform for reproducible biofilm cultivation and analysis, including licensed reactor designs (CDC, Annular, Drip Flow) and microscopy flow cells.

Funding History

2
Total raised:$22.2M
Series A$18M
Seed$4.2M

Opportunities

Growth is driven by the expanding recognition of biofilm-related problems across healthcare and industry, and the ongoing need for standardized testing methods.
The company can leverage its ASTM-standardized products and collaborative R&D model to develop new tools for emerging research areas.

Risk Factors

The company operates in a niche, research-funding-dependent market with limited size.
It faces competition from potential new entrants and technological disruption.
As a small private manufacturer, it is also exposed to supply chain and operational risks.

Competitive Landscape

BST occupies a unique position as the sole licensed manufacturer of several industry-standard biofilm reactors, giving it a significant competitive moat. Competition likely comes from academic labs building custom reactors, generic lab equipment suppliers, and specialized startups focusing on subsets of the market (e.g., microfluidic biofilm chips).